Most digital health startups burn through their runway just trying to find the right decision maker.

Getting a meeting is hard enough.

Getting a corporate giant to actually deploy your workflow tool across their network is another story entirely.

Brilliant clinical software often dies in endless pilot programs.

Founders waste years trying to navigate enterprise bureaucracy from the outside.

It seems MSD is trying to completely bypass this bottleneck.

I listened to their pitch at HLTH Europe and was quite impressed.

They just launched MSD IDEA Studios in Berlin and Singapore.

Backed by a massive venture fund, they are actively looking to invest in digital health adjacencies.

They want to fund startups solving their own internal operational challenges.

This means investing in things like AI care navigation and early disease diagnosis software.

They bring both the funding and the immediate strategic use case.

Scaling a startup to meet the security demands of a giant like MSD requires incredibly resilient architecture.

At YOUR R&D™, we engineer the fault-tolerant backends that make these deep enterprise integrations possible.

We build the secure data foundation while innovators focus on solving clinical problems.

Do you think corporate venture capital is the most reliable growth path for health tech founders today?

#HealthTech#CorporateVentur#DigitalHealth#SoftwareArchitecture#HLTHEurope